Home / Latest Reports / Necrotising Enterocolitis Market

Necrotising Enterocolitis Market By Stage (stage I, Stage Ii, Stage Iii), Diagnosis (imaging, Laboratory Studies, Differential Diagnosis), Treatment (total Parenteral Nutrition (tpn), Gastrointestinal Decompression, Antimicrobial Therapy, Antifungal Treatment, Paracentesis, Other Treatments) And End User (hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers, Other End Users) - Global Industry Analysis And Forecast To 2023

Published On : July 2018 Pages : 170 Category: Biotechnology Report Code : HC071074

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook and Trend Analysis

The Necrotising Enterocolitis Market is expected to witness considerable growth during the forecast period. Necrotising Enterocolitis is the most well-known reason for gastrointestinal-related dreariness and mortality. The most untimely new-born children are more susceptible towards this disease. As indicated by an investigation distributed in the Advances in Neonatal Care (2017), it was evaluated that around 12% of new-born children conceived with the body weight of below 1500 g are probably going to get affected by Necrotizing Enterocolitis. The ascites condition is likewise observed to be related with Stage II and III. The seriousness of the condition pushes the interest for better analysis and treatment approaches. Eminently, the market is relied upon to grow sooner rather than later because of the predominance of Necrotizing Enterocolitis.

Drivers & Restrains Outlook and Trend Analysis

Different factors, for example, enhanced repayment arrangements in developing nations, enhancing administrative system, developing exploration subsidizing, neglected medicinal needs, and expanding government help are ceaselessly adding to the development of the worldwide Necrotising Enterocolitis (NEC) market. The expanding commitment of advertisers is likewise filling the development of the market. For example, on February 15, 2018, Prometic Life Sciences Inc. received the FDA vagrant medication assignment status to its Inter-Alpha-Inhibitor-Proteins (“IAIP”) for the treatment of necrotizing enterocolitis.

Regional Outlook and Trend Analysis

North America is expected to witness considerable growth of the market over the forecast period. Expanding healthcare expenditure, developing appropriation of mechanically propelled items, surging amputee populace, and ideal government activities with respect to automated innovation are a portion of the key drivers in charge of the biggest income share held by North America.

Competitive Insights

The leading players in the market are Astellas Pharma Inc., Becton, Dickinson and Company (BD), Abbott Laboratories Inc., Eli Lilly and Co. and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Necrotising Enterocolitis Market is segmented as follows-

By Stage:

  • Stage I
  • Stage II
  • Stage III

By Diagnosis:

  • Imaging
  • Abdominal X-Ray
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Laparoscopy
  • Angiography
  • Others
  • Laboratory Studies
  • Haemochromocytometric Exam
  • Blood Culture
  • Serum Electrolytes
  • Arterial Blood Gas Analysis
  • Blood Pressure Monitor
  • Differential Diagnosis
  • Ileus Secondary To Neonatal Sepsis
  • Spontaneous Intestinal Perforation
  • Ileal Atresia
  • Intestinal Malrotation
  • Volvulus
  • Neonatal Appendicitis
  • Neonatal Pseudomembranous Colitis
  • Others

By Treatment:

  • Total Parenteral Nutrition (TPN)
  • Gastrointestinal Decompression
  • Antimicrobial Therapy
  • Antifungal Treatment
  • Paracentesis
  • Other Treatments

By End User:

  • Hospitals & Clinics
  • Ambulatory Surgical Center
  • Diagnostic Centers
  • Other End Users

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Necrotising Enterocolitis Market, By Stage, Estimates and Forecast, 2014-2023 ($Million)

·         Stage I

·         Stage II

·         Stage III

·         Necrotising Enterocolitis Market, By Diagnosis, Estimates and Forecast, 2014-2023 ($Million)

·         Imaging

o    Abdominal X-Ray

o    Magnetic Resonance Imaging (MRI)

o    Ultrasound

o    Laparoscopy

o    Angiography

o    Others

·         Laboratory Studies

o    Haemochromocytometric Exam

o    Blood Culture

o    Serum Electrolytes

o    Arterial Blood Gas Analysis

o    Blood Pressure Monitor

·         Differential Diagnosis

o    Ileus Secondary To Neonatal Sepsis

o    Spontaneous Intestinal Perforation

o    Ileal Atresia

o    Intestinal Malrotation

o    Volvulus

o    Neonatal Appendicitis

o    Neonatal Pseudomembranous Colitis

o    Others

·         Necrotising Enterocolitis Market, By Treatment, Estimates and Forecast, 2014-2023 ($Million)

·         Total Parenteral Nutrition (TPN)

·         Gastrointestinal Decompression

·         Antimicrobial Therapy

·         Antifungal Treatment

·         Paracentesis

·         Other Treatments

·         Necrotising Enterocolitis Market, By End User, Estimates and Forecast, 2014-2023 ($Million)

·         Hospitals & Clinics

·         Ambulatory Surgical Center

·         Diagnostic Centers

·         Other End Users

·         Necrotising Enterocolitis Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

o    North America

§  North America Necrotising Enterocolitis Market, By Country

o    U.S. Necrotising Enterocolitis Market

o    Canada Necrotising Enterocolitis Market

o    Mexico Necrotising Enterocolitis Market

o    Europe

§  Europe Necrotising Enterocolitis Market, By Country

o    Germany Necrotising Enterocolitis Market

o    UK Necrotising Enterocolitis Market

o    France Necrotising Enterocolitis Market

o    Russia Necrotising Enterocolitis Market

o    Italy Necrotising Enterocolitis Market

o    Rest of Europe Necrotising Enterocolitis Market

o    Asia-Pacific

§  Asia-Pacific Necrotising Enterocolitis Market, By Country

o    China Necrotising Enterocolitis Market

o    Japan Necrotising Enterocolitis Market

o    South Korea Necrotising Enterocolitis Market

o    India Necrotising Enterocolitis Market

o    Southeast Asia Necrotising Enterocolitis Market

o    Rest of Asia-Pacific Necrotising Enterocolitis Market

o    South America

§  South America Necrotising Enterocolitis Market

o    Brazil Necrotising Enterocolitis Market

o    Argentina Necrotising Enterocolitis Market

o    Columbia Necrotising Enterocolitis Market

o    South Africa Necrotising Enterocolitis Market

o    Rest of South America Necrotising Enterocolitis Market

o    Middle East and Africa

§  Middle East and Africa Necrotising Enterocolitis Market

o    Saudi Arabia Necrotising Enterocolitis Market

o    UAE Necrotising Enterocolitis Market

o    Egypt Necrotising Enterocolitis Market

o    Nigeria Necrotising Enterocolitis Market

o    South Africa Necrotising Enterocolitis Market

o    Rest of MEA Necrotising Enterocolitis Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Necrotising Enterocolitis Market, By Stage

5.1.       Introduction

5.2.       Global Necrotising Enterocolitis Revenue and Market Share by Stage (2017-2027)

5.2.1.  Global Necrotising Enterocolitis Revenue and Revenue Share by Stage (2017-2027)

5.3.       Stage I

5.3.1.  Global Stage I Revenue and Growth Rate (2017-2027)

5.4.       Stage II

5.4.1.  Global Stage II Revenue and Growth Rate (2017-2027)

5.5.       Stage III

5.5.1.  Global Stage III Revenue and Growth Rate (2017-2027)

6.       Necrotising Enterocolitis Market, By Diagnosis

6.1.       Introduction

6.2.       Global Necrotising Enterocolitis Revenue and Market Share by Diagnosis (2017-2027)

6.2.1.  Global Necrotising Enterocolitis Revenue and Revenue Share by Diagnosis (2017-2027)

6.2.2.  Global Necrotising Enterocolitis Revenue by Type (2017-2027)

6.2.3.  Imaging

6.2.3.1.    Global Imaging Revenue by Type (2017-2027)

6.2.3.2.    Global Imaging Revenue and Growth Rate (2017-2027)

6.2.3.3.    Abdominal X-Ray

6.2.3.3.1.    Global Abdominal X-Ray Revenue and Growth Rate (2017-2027)

6.2.3.4.    Magnetic Resonance Imaging (MRI)

6.2.3.4.1.    Global Magnetic Resonance Imaging (MRI) Revenue and Growth Rate (2017-2027)

6.2.3.5.    Ultrasound

6.2.3.5.1.    Global Ultrasound Revenue and Growth Rate (2017-2027)

6.2.3.6.    Laparoscopy

6.2.3.6.1.    Global Laparoscopy Revenue and Growth Rate (2017-2027)

6.2.3.7.    Angiography

6.2.3.7.1.    Global Angiography Revenue and Growth Rate (2017-2027)

6.2.3.8.    Others

6.2.3.8.1.    Global Others Revenue and Growth Rate (2017-2027)

6.2.4.  Laboratory Studies

6.2.4.1.    Global Laboratory Studies Revenue by Type (2017-2027)

6.2.4.2.    Global Laboratory Studies Revenue and Growth Rate (2017-2027)

6.2.4.3.    Haemochromocytometric Exam

6.2.4.3.1.    Global Haemochromocytometric Exam Revenue and Growth Rate (2017-2027)

6.2.4.4.    Blood Culture

6.2.4.4.1.    Global Blood Culture Revenue and Growth Rate (2017-2027)

6.2.4.5.    Serum Electrolytes

6.2.4.5.1.    Global Serum Electrolytes Revenue and Growth Rate (2017-2027)

6.2.4.6.    Arterial Blood Gas Analysis

6.2.4.6.1.    Global Arterial Blood Gas Analysis Revenue and Growth Rate (2017-2027)

6.2.4.7.    Blood Pressure Monitor

6.2.4.7.1.    Global Blood Pressure Monitor Revenue and Growth Rate (2017-2027)

6.2.5.  Differential Diagnosis

6.2.5.1.    Global Differential Diagnosis Revenue by Type (2017-2027)

6.2.5.2.    Global Differential Diagnosis Revenue and Growth Rate (2017-2027)

6.2.5.3.    Ileus Secondary To Neonatal Sepsis

6.2.5.3.1.    Global Ileus Secondary To Neonatal Sepsis Revenue and Growth Rate (2017-2027)

6.2.5.4.    Spontaneous Intestinal Perforation

6.2.5.4.1.    Global Spontaneous Intestinal Perforation Revenue and Growth Rate (2017-2027)

6.2.5.5.    Ileal Atresia

6.2.5.5.1.    Global Ileal Atresia Revenue and Growth Rate (2017-2027)

6.2.5.6.    Intestinal Malrotation

6.2.5.6.1.    Global Intestinal Malrotation Revenue and Growth Rate (2017-2027)

6.2.5.7.    Volvulus

6.2.5.7.1.    Global Volvulus Revenue and Growth Rate (2017-2027)

6.2.5.8.    Neonatal Appendicitis

6.2.5.8.1.    Global Neonatal Appendicitis Revenue and Growth Rate (2017-2027)

6.2.5.9.    Neonatal Pseudomembranous Colitis

6.2.5.9.1.    Global Neonatal Pseudomembranous Colitis Revenue and Growth Rate (2017-2027)

6.2.5.10. Others

6.2.5.10.1. Global Others Revenue and Growth Rate (2017-2027)

7.       Necrotising Enterocolitis Market, By Treatment

7.1.       Introduction

7.2.       Global Necrotising Enterocolitis Revenue and Market Share by Treatment (2017-2027)

7.2.1.  Global Necrotising Enterocolitis Revenue and Revenue Share by Treatment (2017-2027)

7.3.       Total Parenteral Nutrition (TPN)

7.3.1.  Global Total Parenteral Nutrition (TPN) Revenue and Growth Rate (2017-2027)

7.4.       Gastrointestinal Decompression

7.4.1.  Global Gastrointestinal Decompression Revenue and Growth Rate (2017-2027)

7.5.       Antimicrobial Therapy

7.5.1.  Global Antimicrobial Therapy Revenue and Growth Rate (2017-2027)

7.6.       Antifungal Treatment

7.6.1.  Global Antifungal Treatment Revenue and Growth Rate (2017-2027)

7.7.       Paracentesis

7.7.1.  Global Paracentesis Revenue and Growth Rate (2017-2027)

7.8.       Other Treatments

7.8.1.  Global Other Treatments Revenue and Growth Rate (2017-2027)

8.       Necrotising Enterocolitis Market, By End User

8.1.       Introduction

8.2.       Global Necrotising Enterocolitis Revenue and Market Share by End User (2017-2027)

8.2.1.  Global Necrotising Enterocolitis Revenue and Revenue Share by End User (2017-2027)

8.3.       Hospitals & Clinics

8.3.1.  Global Hospitals & Clinics Revenue and Growth Rate (2017-2027)

8.4.       Ambulatory Surgical Center

8.4.1.  Global Ambulatory Surgical Center Revenue and Growth Rate (2017-2027)

8.5.       Diagnostic Centers

8.5.1.  Global Diagnostic Centers Revenue and Growth Rate (2017-2027)

8.6.       Other End Users

8.6.1.  Global Other End Users Revenue and Growth Rate (2017-2027)

9.       Necrotising Enterocolitis Market, By Region

9.1.       Introduction

9.2.       Global Necrotising Enterocolitis Revenue and Market Share by Regions

9.2.1.  Global Necrotising Enterocolitis Revenue by Regions (2017-2027)

9.3.       North America Necrotising Enterocolitis by Countries

9.3.1.  North America Necrotising Enterocolitis Revenue and Growth Rate (2017-2027)

9.3.2.  North America Necrotising Enterocolitis Revenue (Million USD) by Countries (2017-2027)

9.3.3.  U.S.

9.3.3.1.    United States Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.    Canada Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.    Mexico Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.       Europe Necrotising Enterocolitis by Countries

9.4.1.  Europe Necrotising Enterocolitis Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Necrotising Enterocolitis Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.    Germany Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  UK

9.4.4.1.    UK Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  France

9.4.5.1.    France Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.    Russia Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.    Italy Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.    Rest of Europe Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.       Asia-Pacific

9.5.1.  Asia-Pacific Necrotising Enterocolitis Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Necrotising Enterocolitis Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.    China Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.    Japan Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.    Korea Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.    India Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.    Southeast Asia Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.    Rest of Asia-Pacific Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.       South America

9.6.1.  South America Necrotising Enterocolitis Revenue and Growth Rate (2017-2027)

9.6.2.  South America Necrotising Enterocolitis Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.    Brazil Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.    Argentina Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.    Columbia Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.    Rest of South America Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.       Middle East and Africa

9.7.1.  Middle East and Africa Necrotising Enterocolitis Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Necrotising Enterocolitis Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.    Saudi Arabia Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.    United Arab Emirates Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.    Egypt Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.    Nigeria Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.    South Africa Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Rest of Middle East and Africa

9.7.8.1.    Rest of Middle East and Africa Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2017-2027)

10.   Company Profiles

10.1.    Astellas Pharma Inc.

10.1.1.      Business Overview

10.1.2.      Product Portfolio

10.1.3.      Strategic Developments

10.1.4.      Revenue and Market Share

10.2.    Becton Dickinson and Company (BD)

10.2.1.      Business Overview

10.2.2.      Product Portfolio

10.2.3.      Strategic Developments

10.2.4.      Revenue and Market Share

10.3.    Abbott Laboratories Inc.

10.3.1.      Business Overview

10.3.2.      Product Portfolio

10.3.3.      Strategic Developments

10.3.4.      Revenue and Market Share

10.4.    Eli Lilly and Co.

10.4.1.      Business Overview

10.4.2.      Product Portfolio

10.4.3.      Strategic Developments

10.4.4.      Revenue and Market Share

11.   Global Necrotising Enterocolitis Market Competition, by Manufacturer

11.1.    Global Necrotising Enterocolitis Revenue and Market Share by Manufacturer (2017-2017)

11.2.    Global Necrotising Enterocolitis Price by Region (2017-2017)

11.3.    Top 5 Necrotising Enterocolitis Manufacturer Market Share

11.4.    Market Competition Trend

12.   Necrotising Enterocolitis Market Forecast (2027-2023)

12.1.    Global Necrotising Enterocolitis Revenue (Millions USD) and Growth Rate (2027-2023)

12.2.    Necrotising Enterocolitis Market Forecast by Regions (2027-2023)

12.2.1.      North America Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.1.1. United States Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.1.2. Canada Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.1.3. Mexico Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.2.      Europe Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.2.1. Germany Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.2.2. United Kingdom Necrotising Enterocolitiss Market Forecast (2027-2023)

12.2.2.3. France Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.2.4. Russia Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.2.5. Italy Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.2.6. Rest of the Europe Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.3.      Asia-Pacific Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.3.1. China Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.3.2. Japan Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.3.3. Korea Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.3.4. India Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.3.5. Southeast Asia Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.3.6. Rest of Asia-Pacific Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.4.      South America Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.4.1. Brazil Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.4.2. Argentina Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.4.3. Columbia Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.4.4. Rest of South America Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.5.      Middle East and Africa Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.5.1. Saudi Arabia Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.5.2. UAE Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.5.3. Egypt Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.5.4. Nigeria Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.5.5. South Africa Necrotising Enterocolitis Market Forecast (2027-2023)

12.2.5.6. Rest of MEA Necrotising Enterocolitis Market Forecast (2027-2023)

12.3.    Necrotising Enterocolitis Market Forecast by Stage (2027-2023)

12.3.1.      Global Necrotising Enterocolitis Revenue Forecast by Stage (2027-2023)

12.3.2.      Global Necrotising Enterocolitis Revenue Market Share Forecast by Stage (2027-2023)

12.4.    Necrotising Enterocolitis Market Forecast by Diagnosis (2027-2023)

12.4.1.      Global Necrotising Enterocolitis Revenue Forecast by Diagnosis (2027-2023)

12.4.2.      Global Necrotising Enterocolitis Revenue Market Share Forecast by Diagnosis (2027-2023)

12.5.    Necrotising Enterocolitis Market Forecast by Treatment (2027-2023)

12.5.1.      Global Necrotising Enterocolitis Revenue Forecast by Treatment (2027-2023)

12.5.2.      Global Necrotising Enterocolitis Revenue Market Share Forecast by Treatment (2027-2023)

12.6.      Necrotising Enterocolitis Market Forecast by End User (2027-2023)

12.6.1.      Global Necrotising Enterocolitis Revenue Forecast by End User (2027-2023)

12.6.2.      Global Necrotising Enterocolitis Revenue Market Share Forecast by End User (2027-2023)

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Necrotising Enterocolitis Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*